Chargement en cours...
CD8+CD39+ T Cells Mediate Anti-Tumor Cytotoxicity in Bladder Cancer
INTRODUCTION: Although immunotherapy works well in parts of patients with bladder cancer (BLCA), its overall response rate of anti-PD-1 inhibitors remains unsatisfactory. Besides, growing evidence shows that tumor-infiltrating lymphocytes (TILs) immunotherapy has demonstrated excellent efficacy in v...
Enregistré dans:
| Publié dans: | Onco Targets Ther |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8006912/ https://ncbi.nlm.nih.gov/pubmed/33790578 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S297272 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|